Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Fgg-impaired zebrafish present dysfibrinogenemia

July 19, 2022

Thrombogenic effects of allosteric SHP2 inhibitor SHP-099

July 18, 2022

Murine model shows fibrin alpha crosslinking impairment behind thromboembolism

July 18, 2022

PCYOX1 identified as new target for antithrombotic therapy

July 18, 2022

Coagulant Therapeutics presents preclinical data on CT-001

July 18, 2022

Novel hemophilia A murine model to test IdeS proteinase efficacy

July 18, 2022

CM-352 reduces MMP10-driven fibrinolysis in rivaroxaban-associated ICH

July 15, 2022

FVIII-QQ gene transfer therapy shows advantage for treating hemophilia A

July 14, 2022

Limitations of certain mouse models for sickle cell research highlighted

July 8, 2022

New coagulation factor XIa inhibitors discovered at Shanghai Leadingtac Pharmaceutical

July 7, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...